Hyperoside Protected Against Oxidative Stress-Induced Liver Injury via the PHLPP2-AKT-GSK-3β Signaling Pathway In Vivo and In Vitro

Eitemau Tebyg

• Hyperoside Protected Against Oxidative Stress-Induced Liver Injury via the PHLPP2-AKT-GSK-3β Signaling Pathway In Vivo and In Vitro
  gan: Haiyan Xing, et al.
  Cyhoeddwyd: (2020-07-01)
• Crm1-Dependent Nuclear Export of Bach1 is Involved in the Protective Effect of Hyperoside on Oxidative Damage in Hepatocytes and CCl(4)-induced Acute Liver Injury
  gan: Cai, Yongqing, et al.
  Cyhoeddwyd: (2021)
• Bradycardia associated with pegylated liposomal doxorubicin administration: a case report
  gan: Xie, Zhaolu, et al.
  Cyhoeddwyd: (2017)
• Exploitation of the Ability of γ-Tocopherol to Facilitate Membrane Co-localization of Akt and PHLPP1 to Develop PHLPP1-Targeted Akt Inhibitors
  gan: Yan, Ribai, et al.
  Cyhoeddwyd: (2015)
• Physiological activation of Akt by PHLPP1 deletion protects against pathological hypertrophy
  gan: Moc, Courtney, et al.
  Cyhoeddwyd: (2015)